ArticleFrontiers in cardiovascular medicine2026
Associations between metabolic indices and the prevalence of simple renal cysts among hospitalized patients with hypertension in Xinjiang, China: a large-scale cross-sectional study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic dysfunction may be associated with simple renal cysts (SRCs) in patients with hypertension, but the relationships between routinely available metabolic indices and SRC prevalence remain unclear. We therefore aimed to examine the associations between six routinely available metabolic indices and SRC prevalence among hospitalized patients with hypertension. Methods: This cross-sectional study included 35,000 adults hospitalized with hypertension between January 1, 2014, and October 31, 2025, who had complete data required to calculate the metabolic indices and available renal ultrasonography or abdominal CT findings. Patients aged <18 years, pregnant patients, and those with major hepatic, renal, endocrine, urinary tract, malignant, or non-simple cystic kidney conditions were excluded. Additional exclusions included prior mineralocorticoid receptor antagonist use and extreme values. Associations of six metabolic indices with prevalent SRCs were examined using multivariable logistic regression, supplemented by RCS, ROC, subgroup, sensitivity, and E-value analyses. Results: Among 35,000 participants, 7,250 (20.7%) had SRCs. SRC prevalence increased progressively across quartiles of all six metabolic indices (all Conclusion: Higher levels of all six metabolic indices were independently associated with a greater prevalence of SRCs in patients with hypertension, with consistent associations observed for large and multiple cysts. Among the indices evaluated, METS-VF showed the strongest association and the highest observed discriminative performance, suggesting that visceral adiposity-related metabolic dysfunction may be particularly relevant to SRC burden. Prospective studies are needed to confirm the temporal relationship and clinical utility of these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.